GEN News Highlights: Dec 12, 2011

Rainbow to Snap Up n3D’s Three-Dimensional Cell Culturing Technology

(Page 1 of 1)

    Rainbow Biosciences inked a letter of intent to acquire or form a joint venture with n3D Biosciences. Working in collaboration with the MD Anderson Cancer Center and Rice University, n3D has developed a process to enable cell culture in a 3-D environment that more closely mimics their growth in vivo.

    The resulting Bio-Assembler platform uses magnetic levitation to lift cells off a flat surface. Magnetic Nanoshuttle nanoparticles are first delivered to the cells in their culture dish, and a magnetic drive placed on top of the closed dish, which causes the cells to levitate. n3D claims the system enables the rapid formation of 3-D structures and cell-cell interactions, is compatible with virtually any cell type (including primary and stem cells) and standard culturing protocols or diagnostic techniques, and enables 3-D co-culturing. The technique in addition gives scientists the capability to move and shape tissues for invasion studies and tissue engineering.

    Rainbow Biosciences is a division of Rainbow Coral Corp, and has been set up to develop and market bioscience solutions for physicians, researchers, and pharmaceutical engineers. The firm’s headquarters were established in Houston, TX, in November. 


Related content

GEN News Highlights

Insight & Intelligence™

GEN Articles

BLOG biotech

Application Notes

GEN Podcasts

Video Channel

Events

New Products

Best of the Web

GEN Polls

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll